Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2024-2032

Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A8220
Buy Now

Biotechnology Reagents Market Size:

The global biotechnology reagents market size reached US$ 85,410.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 165,819.5 Million by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032. The market is experiencing robust growth, driven by increasing investment in research and development (R&D) activities, rising demand in healthcare diagnostics and drug development, the heightened prevalence of chronic diseases and genetic disorders, and rapid technological advancements in production and automation.

Report Attribute 
Key Statistics
Base Year
Forecast Years
Historical Years
Market Size in 2023
US$ 85,410.1 Million
Market Forecast in 2032
US$ 165,819.5 Million
Market Growth Rate 2024-2032 7.42%

Biotechnology Reagents Market Analysis:

  • Major Market Drivers: The market is driven by the increase in global healthcare demands, particularly in diagnostics and therapeutic development, which necessitates extensive use of biotechnology reagents across various applications, heightened spending on research and development (R&D), and growing cases of chronic conditions and genetic disorders.
  • Key Market Trends: There is a notable trend towards the automation of biotechnological processes, which increases the demand for specialized reagents that are compatible with automated systems, enhancing the speed and accuracy of biotechnological assays.
  • Geographical Trends: North America remains the dominant region due to its advanced research infrastructure, significant research and development (R&D) investments, and robust regulatory environment supporting biotechnology innovations. Other regions are also expanding, fueled by increased healthcare spending, rising research activities, and governmental support to boost biotechnology as a part of national development.
  • Competitive Landscape: Some of the major market players in the biotechnology reagents industry include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation, among many others.
  • Challenges and Opportunities: A major challenge in the market is the high cost and complexity that is involved in producing and maintaining high-quality reagents. However, this also presents an opportunity for market players to innovate in cost-effective production techniques and distribution strategies to make biotechnology reagents more accessible worldwide.

Biotechnology Reagents Market

Biotechnology Reagents Market Trends:

Increasing Spending on Research and Development (R&D) in the Biotechnology Sector

The increase in research and development (R&D) spending within the biotechnology sector by governments and private entities is boosting the growth of the biotechnology reagents industry. This investment is driven by the recognition of biotechnology’s potential to provide solutions in healthcare, agriculture, and environmental conservation. Also, increased funding allows for more extensive and intensive research projects, which, in turn, is responsible for raising the demand for reagents used in many experiments and processes. For example, in the Union Budget 2023-24, the Department of Biotechnology (DBT), India was allotted US$ 162.7 million (Rs. 1,345 crores) to promote R&D, agriculture biotechnology, and many more, according to the latest 2024 update by the India Brand Equity Foundation (IBEF). 

Rising Prevalence of Chronic Diseases and Genetic Disorders

The increase in chronic diseases and genetic disorders has motivated the biotechnology industry to develop new and improved diagnostic and therapeutic solutions. 6 in 10 adults in the US are suffering from chronic diseases. And 4 out of 10 people have more than two chronic conditions, based on the report by the Centers for Disease Control and Prevention. About 21% of the older adults in India reportedly have at least one chronic disease. 17% of geriatric people in rural areas and 29% in urban areas suffer from at least one chronic disease. Hypertension and diabetes account for about 68% of all chronic diseases. This medical need is driving the demand for biotechnology reagents. They are vital in diagnosing conditions at the molecular level and creating genetic therapies.

Growing Applications in the Pharmaceutical and Healthcare Sectors

Biotechnology reagents are essential in the pharmaceutical industry as they are being utilized in drug discovery, pharmacogenomics, and toxicological testing. Growth in this sector is also contributing to the increased biotechnology reagent market revenue. The pharmaceutical sector is growing at an astonishing rate due to increased healthcare spending, better infrastructure, and greater awareness. For instance, by 2030, this sector in India is projected to grow to $130 billion. Additionally, India exports many medications to more than 200 nations. The country supplies over 50% of Africa’s requirement for generics, 40% of generic demand in the US, and 25% of all medicine in the UK. Also, the pharmaceutical industry in the UK has a turnover of 40.8 billion pounds. The growing demand for effective therapeutic drugs and the rising emphasis on accurate diagnostics are key drivers of the rising biotechnology reagents market share.

Biotechnology Reagents Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on technology and application.

Breakup by Technology:

Biotechnology Reagents Market

  • Life Science Reagents
    • PCR
    • Cell Culture
    • Hematology
    • In-Vitro Diagnostics
    • Others
  • Analytical Reagents
    • Chromatography
    • Mass Spectrometry
    • Electrophoresis
    • Flow Cytometry
    • Others

The report has provided a detailed breakup and analysis of the market based on the technology. This includes life science reagents (PCR, cell culture, hematology, In-Vitro diagnostics, and others) and analytical reagents (chromatography, mass spectrometry, electrophoresis, flow cytometry, and others).

As per the biotechnology reagent market analysis and outlook, the life science reagents segment is a significant part of the market, encompassing products used in molecular biology, cell biology, genetics, and other biomedical research fields. They are essential for a variety of applications, including deoxyribonucleic acid (DNA)/ribonucleic acid (RNA) synthesis and purification, protein analysis, gene expression, and cell culture operations. Moreover, the increasing focus on research and development (R&D) in genomics and proteomics, advancements in molecular diagnostics, and the rising prevalence of chronic diseases that require novel therapeutic approaches are boosting the biotechnology reagents industry demand.

Based on the biotechnology reagents market trends and overview, analytical reagents form another crucial market segment and are predominantly used in chemical analysis, quality control, and clinical diagnostics. They are vital for spectrometry, chromatography, electrophoresis, and microscopy techniques. Analytical reagents benefit from the stringent regulatory requirements for product quality and safety in industries such as pharmaceuticals, food and beverage (F&B), and environmental testing.

Breakup by Application:

  • Protein Synthesis and Purification
  • Gene Expression
  • DNA and RNA Analysis
  • Drug Testing
  • Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes protein synthesis and purification, gene expression, DNA and RNA analysis, drug testing, and others.

As per the biotechnology reagent market segmentation, the protein synthesis and purification segment addresses the high demand for specialized reagents required in various processes involved in producing and isolating specific proteins. They are crucial in biotechnological applications such as enzyme production, pharmaceuticals, research pertaining to cellular functions, and diseases. Moreover, the widespread expansion of proteomics research and the increasing importance of biologic drugs in treatments, which rely heavily on the precise synthesis and purification of proteins, is favoring the market growth.

Based on the biotechnology reagents industry research, the gene expression segment encompasses reagents used in analyzing and quantifying gene expression levels within various cell types and conditions. It is essential in research areas like developmental biology, cancer research, and genetic disorder studies, where understanding gene activity is pivotal. Moreover, rapid advances in high-throughput technologies and the growing use of gene expression in personalized medicine to tailor treatments based on an individual's genetic makeup are enhancing the biotechnology reagent market value.

The deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) analysis segment includes reagents used in genomic studies, such as sequencing, polymerase chain reaction (PCR) amplification, and molecular diagnostics. It is critical for advancing genetic research, identifying infectious diseases, and developing genetic markers in clinical diagnostics. Furthermore, the rapid advancements in genomic technologies, decreased sequencing costs, and the broader adoption of next-generation sequencing techniques across various fields, including forensic science, oncology, and microbiology, are bolstering the market growth. 

Based on the biotechnology reagent market research report, the drug testing segment involves reagents used in pharmacological research to analyze the efficacy, stability, and safety of new drug compounds. It is vital in the preclinical and clinical stages of drug development. Additionally, the increasing global pharmaceutical R&D expenditures, the rising demand for new therapeutic drugs, and stringent regulatory standards requiring comprehensive drug testing are favoring the market growth.

Breakup by Region:

Biotechnology Reagents Market

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest biotechnology reagents market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for biotechnology reagents.

According to the biotechnology reagent market forecast, North America is the largest segment, driven by robust research infrastructure, substantial investments in biotechnology and pharmaceutical sectors, and the presence of leading biotech and healthcare companies. Moreover, the strong governmental support through funding and favorable regulatory policies aimed at advancing biotechnological research and healthcare innovations is catalyzing the market growth. Additionally, the rising adoption of advanced technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR), next-generation sequencing (NGS), and personalized medicine, is boosting the market growth. Besides this, the presence of a well-established academic and research environment, coupled with collaborations between research institutes and the biotechnology industry, is enhancing the market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the biotechnology reagents industry include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

    (Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
  • The top biotechnology reagent industry companies are engaging in a variety of strategic initiatives to strengthen their market position and drive growth. They are investing in research and development (R&D) to innovate and improve the quality, efficiency, and application range of their reagents. For instance, they are focusing on developing more specialized reagents for advanced research areas, such as genomics, proteomics, and personalized medicine. Additionally, major players are expanding their global presence through mergers and acquisitions, partnerships with biotechnological and pharmaceutical companies, and collaborations with academic and research institutions. Moreover, they are emphasizing regulatory approvals across different regions to ensure that their offerings meet the stringent standards required in critical research and clinical applications.

Biotechnology Reagents Market News:

  • In June 2022, Agilent Technologies Inc. announced that previously CE-IVD marked instruments, kits, and reagents were released as IVDR Class A on May 26, 2022. This is in compliance with the new EU In Vitro Diagnostic Regulation (IVDR) regulation.
  • In January 2022, Thermo Fisher completed the acquisition of PeproTech for a total cash purchase price of approximately USD 1,850.00 million. PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products and will enable Thermo Fisher to provide customers significant benefits through an integrated offering.

Biotechnology Reagents Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Technology
  • Application
  • Region
Technologies Covered
  • Life Science Reagents: PCR, Cell Culture, Hematology, In-Vitro Diagnostics, Others
  • Analytical Reagents: Chromatography, Mass Spectrometry, Electrophoresis, Flow Cytometry, Others
Applications Covered Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the global biotechnology reagents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biotechnology reagents market?
  • What is the impact of each driver, restraint, and opportunity on the global biotechnology reagents market?
  • What are the key regional markets?
  • Which countries represent the most attractive biotechnology reagents market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the biotechnology reagents market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biotechnology reagents market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biotechnology reagents market?

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the biotechnology reagents market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global biotechnology reagents market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the biotechnology reagents industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2024-2032
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More